| Structure |
Chemical Name |
CAS |
MF |
 |
Linagliptin Impurity I |
|
|
 |
1H-Pyrrole-3-carbonitrile,5-(2-fluorophenyl)-1-(3-pyridinylsulfonyl)- |
1807642-39-2 |
C16H10FN3O2S |
![4-amino-1-[(2RS)-2-(2,4-difluorophenyl)-2-hydroxy-3(1H-
1,2,4-triazol-1-yl)propyl]-4H-1,2,4-triazolium](/CAS/20180629/GIF/749821-19-0.gif) |
4-amino-1-[(2RS)-2-(2,4-difluorophenyl)-2-hydroxy-3(1H-
1,2,4-triazol-1-yl)propyl]-4H-1,2,4-triazolium |
749821-19-0 |
C13H14F2N7O+ |
|
|
Canagliflozin Defluoro Impurity |
|
|
|
|
Dapagliflozin Impurity 6 |
|
|
 |
Imatinib Impurity 7 |
581076-64-4 |
C8H12N4 |
 |
Nilotinib Impurity 1 |
641571-05-3 |
C28H22F3N7O |
|
|
Riociguat Impurtiy 1 |
|
|
 |
Riociguat Impurtiy 6 |
1702271-98-4 |
C18H17FN8 |
 |
Axitinib Impurity 4 |
1443118-73-7 |
C22H20N4OS |
 |
Brimonidine Impurity E |
168329-48-4 |
C9H8BrN5 |
|
|
Dapagliflozin Impurity G |
|
|
|
|
Dapoxetine Impurity B |
|
|
|
|
Esomeprazole EP Impurity |
|
|
 |
Fesoterodine Diol Dimer |
1428856-45-4 |
C44H60N2O3 |
 |
Gimeracil Impurity |
17902-24-8 |
C8H9ClN2O3 |
|
|
Pramipexole Impurity H |
|
|
 |
Quercetin 3-rutinoside 7-glucoside |
30311-61-6 |
C33H40O21 |
 |
(R)-N-DeMethyl Dapoxetine |
1202160-36-8 |
C20H21NO |
 |
14,15-Dehydro Budesonide |
131918-64-4 |
C25H32O6 |
 |
2-(BenzylMethylaMino)-3',4'-dihydroxyacetophenone |
36467-25-1 |
C16H17NO3 |
 |
2'-O-(5'-Deoxy-β-D-ribofuranosyl) Capecitabine |
1262133-66-3 |
C20H30FN3O9 |
 |
4-Defluoro-4-hydroxy Gefitinib |
847949-50-2 |
C22H25ClN4O4 |
 |
5-Methyl-2-(1H-1,2,3-triazol-1-yl)benzoic acid |
1149352-55-5 |
C10H9N3O2 |
![9-ethyl-8-iodo-6,6-diMethyl-11-oxo-6,11-dihydro-5H-benzo[b]carbazole-3-carbonitrile](/CAS/GIF/1256584-80-1.gif) |
9-ethyl-8-iodo-6,6-diMethyl-11-oxo-6,11-dihydro-5H-benzo[b]carbazole-3-carbonitrile |
1256584-80-1 |
C21H17IN2O |
|
|
9-ethyl-8-iodo-6,6-diMethyl-11-oxo-6,11-dihydro-5H-benzo[b]carbazole-3-carbonitrile |
1256584-80-1 |
C21H17IN2O |
 |
Palonosetron Impurity 7 |
177932-92-2 |
C18H24N2O |
 |
4-(2,3-Dichlorophenyl)-2,6-diMethyl-1,4-dihydropyridine-3,5-dicarboxylic acid |
138279-32-0 |
C15H13Cl2NO4 |
|
|
IMp. A (EP) as Hydrochloride: 3-[[[2-[(DiaMinoMethylene)aMino]thiazol-4-yl]- Methyl]sulphanyl]propaniMidaMide Hydrochloride |
|
|
![(1R,2R,4S)-2-[(tert-butoxycarbonyl)aMino]-4-[(diMethylaMino)carbonyl]cyclohexyl Methanesulfonate](/CAS/20150408/GIF/929693-31-2.gif) |
(1R,2R,4S)-2-[(tert-butoxycarbonyl)aMino]-4-[(diMethylaMino)carbonyl]cyclohexyl Methanesulfonate |
929693-31-2 |
C15H28N2O6S |
 |
7-Methoxy-4-oxo-1,4-dihydroquinoline-6-carboxaMide |
417724-81-3 |
C11H10N2O3 |
![[1,4'-Bipiperidine]-1'-carboxylic acid](/CAS/20150408/GIF/1026078-50-1.gif) |
[1,4'-Bipiperidine]-1'-carboxylic acid |
1026078-50-1 |
C11H20N2O2 |
![4-[[3-(1-Methylethyl)-2-oxo-5-oxazolidinyl]methoxy]benzaldehyde](/CAS/20150408/GIF/1173203-26-3.gif) |
4-[[3-(1-Methylethyl)-2-oxo-5-oxazolidinyl]methoxy]benzaldehyde |
1173203-26-3 |
C14H17NO4 |
|
|
EMpagliflozin iMpurity 9 |
|
|
 |
EMpagliflozin iMpurity 14 |
2137418-13-2 |
C23H27ClO8 |
 |
Avatrapa impurity 12 |
570403-04-2 |
C23H24Cl3N5OS2 |
|
|
ibrutinib iMpurity A |
|
|
|
|
Sunitinib iMpurity E |
|
|
 |
Rosuvastatin EP impurity H |
1335110-44-5 |
C22H28FN3O6S |
|
|
Saxagliptin Impurity 4 (Deoxy Saxagliptin) |
|
|
 |
Betamethasone EP Impurity D |
52619-05-3 |
C25H33FO7 |
 |
Dihydropenicillin F Potassium Salt |
31447-86-6 |
C14H23KN2O4S |
 |
Etoricoxib Impurity 7 |
646459-39-4 |
C20H21N3O2S |
 |
Mupirocin Impurity D |
|
C26H44O9 |
 |
Pazopanib Related Compound 2 |
1226500-02-2 |
C26H23ClN10 |
 |
Phenylephrine EP Impurity D |
1367567-95-0 |
C16H19NO2 |
 |
Verapamil Impurity O |
959011-16-6 |
C27H38N2O4 |
![1,1′-[(1-Methylethyl)imino]bis[3-[4-(2-methoxyethyl)phenoxy]-2-propanol hydrochloride](/CAS/20211123/GIF/1486464-40-7.gif) |
1,1′-[(1-Methylethyl)imino]bis[3-[4-(2-methoxyethyl)phenoxy]-2-propanol hydrochloride |
1486464-40-7 |
C27H42ClNO6 |
 |
4'-FLUOROCYCLOPROPANECARBOXANILIDE |
2354-89-4 |
C10H10FNO |
 |
Rivaroxaban Impurity H |
1807455-76-0 |
C25H24Cl2N4O6S2 |
|
|
Vonoprazan impurity A |
|
|
 |
methyl(E)-4-(methylamino)but-2-enoate |
915788-22-6 |
C6H11NO2 |
|
|
methyl(E)-4-(methylamino)but-2-enoate |
915788-22-6 |
C6H11NO2 |
|
|
Levomilnacipran impurity |
|
|
|
|
Sofosbuvir IMpurity 4 |
|
|
 |
1,3-bis(4-isobutylphenyl)butan-1-one |
|
C24H32O |
 |
6-isobutyl-3-methyl-2,3-dihydro-1H-inden-1-one |
1340024-54-5 |
C14H18O |
 |
Edoxaban impurity 1 |
41374-72-5 |
C9H10N2O3 |
|
|
Canagliflozin Impurity 18 |
|
|
|
|
Canagliflozin Impurity 23 |
|
|
|
|
Carfilzomib Impurity 4 |
|
|
 |
Lenvatinib Impurity 2 |
2380197-90-8 |
C28H22ClN5O5 |
 |
FeBuxostat Impurity 33 |
100118-38-5 |
C12H14O5 |
 |
(S)-3-(4-phenoxyphenyl)-1-(piperidin-3-yl) |
1642630-12-3 |
C22H22N6O |
 |
Latamoxef Impurity 1 |
75007-70-4 |
C19H20N6O7S |
 |
Amlodipine iMpurity K |
1809326-44-0 |
C18H21ClN2O5 |
 |
Cabozantinib impurity 4 |
95932-39-1 |
C11H15NO3 |
 |
Rosuvastatin EP Impurity C |
1620823-61-1 |
C22H27FN3NaO6S |
 |
6,7-bis(2-methoxyethoxy)-N-phenylquinazolin-4-amine |
1145671-52-8 |
C20H23N3O4 |
 |
(3R,4R,5S)-ethyl 4-acetamido-5-amino-3-isopropoxycyclohex-1-enecarboxylate |
1052063-36-1 |
C14H24N2O4 |
 |
4-(N-(tert-butyl)acetamido)-5-(diallylamino)-3-(pentan-3-yloxy)cyclohex-1-enecarboxylate |
941296-96-4 |
C16H28N2O4 |
 |
(2R,5S)-5-(4-amino-5-fluoro-2-oxopyrimidin-1(2H)-yl)-1,3-oxathiolane-2-carboxylic acid |
|
C8H8FN3O4S |
 |
Amlodipine Impurity 10 |
2170104-51-3 |
C26H31ClN2O8S |
 |
Apixaban Impurity 15 |
1466571-07-2 |
C21H20N4O4 |
 |
Clopidogrel Impurity 8 |
|
C15H14ClNO2S |
![Acyclovir Impurity I: 7,9'-[Ethylene-bis(oxymethylene)] Bis (2-amino-1-9-dihydro-6H-purin-6-one)](/CAS/20200515/GIF/1797832-75-7.gif) |
Acyclovir Impurity I: 7,9'-[Ethylene-bis(oxymethylene)] Bis (2-amino-1-9-dihydro-6H-purin-6-one) |
1797832-75-7 |
C14H16N10O4 |
 |
Nilotinib genotoxic impurity 3 |
915711-42-1 |
C19H17F3N4O |
 |
Dapagliflozin Open Ring |
2100872-88-4 |
C21H27ClO7 |
|
|
Rortezide impurity |
|
|
|
|
Aprepitant Impurity 2 |
|
|
|
|
Cabozantinib Impurity A |
|
|
|
|
Loxoprofen Impurity E |
|
|
 |
(R)-4-Propylpyrrolidin-2-one |
930123-37-8 |
C7H13NO |
 |
Rocuronium Bromide Intermediate B Impurity E-1 |
1190105-60-2 |
C29H48N2O3 |
 |
4-Chloro-2-propylsulfanyl-pyrimidine |
1351990-36-7 |
C7H9ClN2S |
 |
benzyl (S)-2-(2-(benzofuran-6-carbonyl)-5,7-dichloro-1,2,3,4-tetrahydroisoquinoline-6-carboxamido)-3-(3-(methylsulfonyl)phenyl)propanoate |
1194550-67-8 |
C36H30Cl2N2O7S |
![D-Proline, 1-[(2S)-3-mercapto-2-methyl-1-oxopropyl]-](/CAS/20180528/GIF/119238-52-7.gif) |
D-Proline, 1-[(2S)-3-mercapto-2-methyl-1-oxopropyl]- |
119238-52-7 |
C9H15NO3S |
![2,4(1H,3H)-Pyrimidinedione,5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]-, (2S-cis)- (9CI)](/CAS/20200119/GIF/145281-92-1.gif) |
2,4(1H,3H)-Pyrimidinedione,5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]-, (2S-cis)- (9CI) |
145281-92-1 |
C8H9FN2O4S |
![Cyclopentanecarboxylic acid, 1-[(1-oxopentyl)amino]-](/CAS/20180529/GIF/15026-80-9.gif) |
Cyclopentanecarboxylic acid, 1-[(1-oxopentyl)amino]- |
15026-80-9 |
C11H19NO3 |
 |
L-Phenylalanine, N-L-leucyl-, methyl ester |
38155-18-9 |
C16H24N2O3 |
![Ethanol, 2-[(2-chloroethyl)amino]-](/CAS/20180529/GIF/3890-98-0.gif) |
Ethanol, 2-[(2-chloroethyl)amino]- |
3890-98-0 |
C4H10ClNO |
 |
5-Methylarabinosylcytosine |
6829-31-8 |
C10H15N3O5 |
 |
Anthranilic acid, N-furfuryl-5-sulfamoyl- |
4818-85-3 |
C12H12N2O5S |
 |
1,3-Benzodioxol-4-ol |
69393-72-2 |
C7H6O3 |
 |
1H-Benzimidazole, 6-bromo-2-methyl-4-(phenylmethoxy)- |
774582-60-4 |
C15H13BrN2O |
 |
ethyl 4-dimethylamino-3-hydroxy-butanoate |
90227-57-9 |
C8H17NO3 |
|
|
ethyl 4-dimethylamino-3-hydroxy-butanoate |
90227-57-9 |
C8H17NO3 |
 |
2(1H)-Pyridinone, 3,4-dihydro- |
57147-25-8 |
C5H7NO |
 |
2-Diethylamino-N-(2,5-dimethyl-phenyl)-acetamide |
857570-37-7 |
C14H22N2O |
 |
(S)-1-Benzyl-3-N-Boc-aminopiperidine |
216854-24-9 |
C17H26N2O2 |